Healthcare provider profile · identity verified

Chloe Leeann Balanda, MD

Family Practice · GRAND RAPIDS, MI · NPI 1720640741

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	554	196
Levothyroxine Sodium	Levothyroxine Sodium	432	146
Lisinopril	Lisinopril	368	123
Losartan Potassium	Losartan Potassium	348	113
Amlodipine Besylate	Amlodipine Besylate	309	106
Omeprazole	Omeprazole	306	98
Metoprolol Succinate	Metoprolol Succinate	211	74
Gabapentin	Gabapentin	165	37
Metformin Hcl	Metformin Hcl	155	49
Rosuvastatin Calcium	Rosuvastatin Calcium	151	56
Sertraline Hcl	Sertraline Hcl	150	49
Hydrochlorothiazide	Hydrochlorothiazide	136	52
Alendronate Sodium	Alendronate Sodium	107	34
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	106	43
Hydroxyzine Hcl	Hydroxyzine Hcl	101	39
Metformin Hcl Er	Metformin Hcl	100	39
Simvastatin	Simvastatin	100	33
Bupropion Xl	Bupropion Hcl	97	32
Fluticasone Propionate	Fluticasone Propionate	97	49
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	97	33
Metoprolol Tartrate	Metoprolol Tartrate	96	36
Pravastatin Sodium	Pravastatin Sodium	95	36
Duloxetine Hcl	Duloxetine Hcl	93	32
Diclofenac Sodium	Diclofenac Sodium	89	50
Eliquis	Apixaban	88	19
Tamsulosin Hcl	Tamsulosin Hcl	86	28
Atenolol	Atenolol	82	31
Fluoxetine Hcl	Fluoxetine Hcl	80	24
Citalopram Hbr	Citalopram Hydrobromide	79	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	18
Albuterol Sulfate Hfa	Albuterol Sulfate	76	39
Montelukast Sodium	Montelukast Sodium	74	26
Escitalopram Oxalate	Escitalopram Oxalate	72	25
Tramadol Hcl	Tramadol Hcl	69	14
Trazodone Hcl	Trazodone Hcl	68	31
Potassium Chloride	Potassium Chloride	65	25
Januvia	Sitagliptin Phosphate	62	22
Allopurinol	Allopurinol	61	22
Pantoprazole Sodium	Pantoprazole Sodium	60	24
Meloxicam	Meloxicam	59	20
Famotidine	Famotidine	58	22
Furosemide	Furosemide	58	31
Ipratropium Bromide	Ipratropium Bromide	58	27
Ozempic	Semaglutide	57	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	17
Glipizide	Glipizide	46	17
Celecoxib	Celecoxib	45	16
Spironolactone	Spironolactone	45	17
Venlafaxine Hcl Er	Venlafaxine Hcl	45	14
Glimepiride	Glimepiride	44	16
Meclizine Hcl	Meclizine Hcl	42	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	41	suppressed
Trulicity	Dulaglutide	41	12
Estradiol	Estradiol	40	14
Oxybutynin Chloride	Oxybutynin Chloride	39	18
Tizanidine Hcl	Tizanidine Hcl	39	18
Lovastatin	Lovastatin	36	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	11
Mounjaro	Tirzepatide	35	12
Triamcinolone Acetonide	Triamcinolone Acetonide	34	17
Zolpidem Tartrate	Zolpidem Tartrate	34	suppressed
Xarelto	Rivaroxaban	33	suppressed
Alprazolam	Alprazolam	32	13
Clopidogrel	Clopidogrel Bisulfate	32	16
Carvedilol	Carvedilol	31	16
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Methocarbamol	Methocarbamol	31	11
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Jardiance	Empagliflozin	30	13
Chlorthalidone	Chlorthalidone	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	29	11
Valacyclovir	Valacyclovir Hcl	28	suppressed
Ketoconazole	Ketoconazole	27	12
Acyclovir	Acyclovir	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Glipizide Er	Glipizide	25	11
Ibuprofen	Ibuprofen	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Azithromycin	Azithromycin	20	15
Prednisone	Prednisone	20	18
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	13
Warfarin Sodium	Warfarin Sodium	19	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Armour Thyroid	Thyroid,pork	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Ramipril	Ramipril	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Doxepin Hcl	Doxepin Hcl	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	14	suppressed
Ciclopirox	Ciclopirox	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Naproxen	Naproxen	14	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Baclofen	Baclofen	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Finasteride	Finasteride	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Glyburide	Glyburide	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Cephalexin	Cephalexin	11	11
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error